Hyponatraemia in Patients With Severe Motor and Intellectual Disabilities: Possible Role of Antiseizure Medications
Journal of Intellectual Disability Research · 08.06.2026
DOI: 10.1111/jir.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intellectual Disability Research, online erschienen am 08.06.2026. Verfasst von Miyoko Tokushima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Hospital Organization Higashisaga Hospital, Miyaki-machi, Saga, Japan. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic hyponatraemia is highly prevalent in older adults and is associated with various adverse health outcomes; however, its prevalence among individuals with severe motor and intellectual disability (SMID) remains unclear. This study aimed to determine the prevalence of hyponatraemia in hospitalized patients with SMID and to identify potential contributing factors.
Methods
We retrospectively analysed serum sodium (sNa) levels in patients with SMID admitted to our hospital. Hyponatraemia was defined as an sNa level < 135 mEq/L. Demographic and clinical data, including age, sex, body weight, nutritional management and medication status, were collected. Serum concentrations of antiseizure medications (ASMs) were evaluated in patients receiving these treatments.
Results
A total of 122 patients were included. The primary diagnoses were cerebral palsy (57.3%), sequelae of intracranial infection (11.4%), hypoxic encephalopathy (10.7%), drug‐resistant epilepsy (9.0%), sequelae of intracranial haemorrhage (4.9%) and congenital disorders including chromosomal abnormalities (6.5%). Hyponatraemia was identified in 22 patients (18.0%). Epilepsy was present in 112 patients, and 93 were receiving ASM therapy. No significant association was observed between hyponatraemia and primary diagnosis. However, univariate analyses revealed that the use of multiple ASMs was significantly associated with hyponatraemia ( p = 0.028). Multiple regression analysis demonstrated that higher serum levels of carbamazepine ( p < 0.0001) and phenytoin ( p = 0.0026) were significantly associated with lower sNa levels.
Conclusions
In our hospital, 18% of patients with SMID exhibited hyponatraemia. Careful monitoring of serum sodium levels is warranted in patients with SMID and epilepsy treated with carbamazepine or phenytoin.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, National Hospital Organization Higashisaga Hospital, Miyaki-machi, Saga, Japan.
ORCID-Profile: Miyoko Tokushima, Shuichi Yamamoto
Zitieren
APA
Tokushima, M., Yokota, G., Ueno, C., Inada, Y., Jinnouchi, K., Nakanishi, M., & Yamamoto, S. (2026). Hyponatraemia in Patients With Severe Motor and Intellectual Disabilities: Possible Role of Antiseizure Medications. Journal of Intellectual Disability Research. https://doi.org/10.1111/jir.70127
Vancouver
Tokushima M, Yokota G, Ueno C, Inada Y, Jinnouchi K, Nakanishi M, et al. Hyponatraemia in Patients With Severe Motor and Intellectual Disabilities: Possible Role of Antiseizure Medications. Journal of Intellectual Disability Research. 2026. doi:10.1111/jir.70127
BibTeX
@article{Tokushima2026,
author = {Tokushima, Miyoko and Yokota, Goro and Ueno, Chika and Inada, Yukiko and Jinnouchi, Kumiko and Nakanishi, Miki and Yamamoto, Shuichi},
title = {Hyponatraemia in Patients With Severe Motor and Intellectual Disabilities: Possible Role of Antiseizure Medications},
journal = {Journal of Intellectual Disability Research},
year = {2026},
doi = {10.1111/jir.70127}
}
EUVIMED